Securities code: 688506 Securities abbreviation: Baili Tianheng Announcement No.: 2025-031

Sichuan Baili Tianheng Pharmaceutical Co., Ltd

In 2025, the application for the issuance of A shares to specific targets was applied for and acquired Shanghai Securities

Announcement of the acceptance of the exchange

The board of directors and all directors of the company guarantee that there are no false records, misleading statements or material omissions in the content of this announcement, and assume legal responsibility for the authenticity, accuracy and completeness of its content in accordance with the law.

Sichuan Baili Tianheng Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") on April 16, 2025

The Shanghai Stock Exchange (hereinafter referred to as the "Shanghai Stock Exchange") received the "Notice on Accepting the Application for the Issuance of Securities by Listed Companies on the Science and Technology Innovation Board of Sichuan Baili Tianheng Pharmaceutical Co., Ltd." (SSE Keshen (Refinancing) [2025] No. 37) issued by the Shanghai Stock Exchange (hereinafter referred to as the "Shanghai Stock Exchange"), and the Shanghai Stock Exchange checked the prospectus and related application documents submitted by the company for the issuance of securities by listed companies on the Science and Technology Innovation Board in accordance with the relevant regulations, and decided to accept and review the application documents in accordance with the statutory form.

The company's issuance of A-shares to specific targets is subject to the review of the Shanghai Stock Exchange and the decision of the China Securities Regulatory Commission (hereinafter referred to as the "China Securities Regulatory Commission") to approve the registration before it can be implemented.

The company will fulfill its information disclosure obligations in a timely manner according to the progress of the matter, and investors are requested to pay attention to investment risks.

The announcement is hereby made.

Board of Directors of Sichuan Baili Tianheng Pharmaceutical Co., Ltd

April 17, 2025